Honestly, I wasn’t sure that Angels for Change could help because we are not located in USA, but they really did a wonderful job in no time.
At Angels for Change, we are proud to participate in the important work of the End Drug Shortages Alliance — serving as both an EDSA member organization and advising partner in the Drug Resiliency & Transparency Pilot.
The initial phase of the pilot demonstrated a powerful truth: when leaders come together early through trusted, neutral governance, transparency delivers real planning value.
Angels for Change today announced that the Mark Cuban Cost Plus Drug Company has completed the Preparation and Protective phases of Project PROTECT for Carboplatin Injection and Methotrexate Injection—two essential oncology medicines currently in nationwide shortage. This milestone strengthens onshore readiness and improves supply availability for patients across the United States.
New from Angels for Change: the launch of our Policy Lab.
The A4C Policy Lab brings together patients, clinicians, policymakers, and industry leaders to turn frontline experience into actionable policy solutions that address drug shortages at their root.
Last week on January 29th, 2026, Angels for Change convened a sold-out National Policy Lab on Capitol Hill in the historic Kennedy Caucus Room to tackle one of the most urgent issues in healthcare: the U.S. drug shortage crisis.
Angels for Change is translating patient harm into real-world policy solutions. This Policy Lab wasn’t a conference — it was a working session focused on collaboration, candor, and outcomes, with patients at the center of every solution.
Angels for Change — 2025 Year in Review
From supporting patients through dozens of different shortage crisis to launching a first-of-its-kind oncology resiliency program to shaping national policy conversations, 2025 was a year of bold action and patient-driven progress.
Together with partners across healthcare, government, and industry, we:
Protected patients during critical drug shortages
Launched Project GOLD to proactively safeguard cancer care
Protected 4 addition essential medicines for the American people with Project PROTECT
Elevated patient voices in policy and supply chain reform
Built momentum toward a more resilient medicine supply system
See how collaboration, transparency, and patient leadership are driving lasting change.
Nearly half of U.S. drug shortages, 47%, are tied to sudden spikes in demand, according to new data from the USP Medicine Supply Map. Angels for Change Project GOLD is highlighted in the article as a solution-oriented initiative that uses demand signals and buffer supply to help protect patients from shortages.
SHARE YOUR “WHY”
Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.

